Beside cases with germline variants predisposing to AML—three DDX41 mutations24, one CSF3R mutation and one 14q32.2 duplication25—, this group comprised all seven patients with TP53 mutations (Fig. 5b, Supplementary Fig. 9). The gene discussed is TP53; the disease is acute myeloid leukemia.